Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis-Reference-Cited by-同舟云学术

Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis

Published:2011-06 Issue:11 Volume:79 Page:1217-1227
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Pereira Rafael L.,Buscariollo Bruna N.,Corrêa-Costa Matheus,Semedo Patricia,Oliveira Cassiano D.,Reis Vanessa O.,Maquigussa Edgar,Araújo Ronaldo C.,Braga Tárcio T.,Soares Maria F.,Moura Ivan C.,Malheiros Denise M.A.C.,Filho Alvaro Pacheco-Silva,Keller Alexandre C.,Câmara Niels O.S.

Publisher

Elsevier BV

Subject

Nephrology

Reference50 articles.

1. Life expectancy benefits of cancer screening in the end-stage renal disease population;LeBrun;Am J Kidney Dis,2000

2. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998;Seikaly;Pediatr Transplant,2001

3. Primum non nocere: should adults with idiopathic FSGS receive steroids?;Franceschini;Semin Nephrol,2003

4. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis;Kerjaschki;J Clin Invest,2001

5. Integrin-linked kinase as a candidate downstream effector in proteinuria;Kretzler;FASEB J,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of Angiotensin-(1−7) with kinins in the kidney circulation: Role of B1 receptors;Peptides;2024-09

2. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice;Clinical Science;2022-05

3. Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice;Frontiers in Molecular Biosciences;2020-05-20

4. Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN;Journal of the American Society of Nephrology;2019-11-26

5. Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis;Arthritis Research & Therapy;2019-01-08